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Calciphylaxis, or calciﬁc uremic arteriolopathy, commonly aﬀects people with end-stage renal disease and carries with it a high
rate of morbidity and mortality. Here, we present the unusual case of a 56-year-old woman, with extensive medical problems, who
developed calciphylaxis in the presence of primary hyperparathyroidism. Our patient initially presented with bilateral, exquisitely
tender thigh lesions.The diagnosis of calciphylaxis was rendered histologically by extensive calciﬁcation of the subcutaneous blood
vessels. Subsequent parathyroidectomy identiﬁed the presence of a hyperactive mediastinal parathyroid adenoma, weighing 0.62
grams. Postoperatively, the patient had normalization of hypercalcemia and parathyroid hormone levels, with subsequent healing
of her thigh wounds. Currently, there have been sixteen cases described in the English literature, with only nine being oﬀered
a potentially therapeutic parathyroidectomy. It is contingent upon the vigilant physician to diagnose and properly manage this
diﬃcult yet treatable condition.
1.Introduction
Calciphylaxis is a rare disease entity ﬁrst described by Bryant
and White in 1898 to characterizea syndrome exempliﬁed by
vascular calciﬁcations with cutaneous necrosis [1]. Attempts
to shed light on its pathophysiology was undertaken by
Selye et al. in 1962 using a rat model to induce calcinosis
through a series of experimental steps [2, 3]. The condition
w a sr e p r o d u c e di nn e p h r e c t o m i z e dr a t sa sw e l la st h o s e
challenged with sensitizers such as parathyroid hormone
(PTH) and vitamin D [2, 3]. A series of sensitization events
appears necessary to alter the calcium homeostasis prior to
the induction of systemic calcinosis with another challenger
agent [2, 3]. Therefore, patients can develop calciphylaxis
even after renal transplantation or in the absence of end-
stagerenaldiseasesuchashyperparathyroidism[4–6].Asthe
disease is multifactorial, many predisposing conditions con-
tribute to the development of this serious disease, including
morbidobesity,diabetesmellitus,malnutrition,liverdisease,
misuse of vitamin D and calcium-based phosphate binders,
or coumadin intake [4–7].
The disease ﬁrst gained notoriety after Gipstein et al.
reported a series of 11 patients with calciphylaxis with
concurrent end-stage renal disease [8]. Since his description,
the incidence appears to be increasing within the last decade,
aﬄicting 1%–4% of patients with end-stage renal disease [4,
6]. Attempts to characterize this patient population seem to
concentrate on Caucasians with a female to male ratio of 3 to
1[ 4, 6]. Although end-stage renal disease (ESRD) is the most
likely culprit to result in disorders of calcium homeostasis,
other conditions such as secondary hypercalcemia, hyper-
parathyroidism, sarcoidosis, or underlying connective tissue2 International Journal of Endocrinology
disease can also be potential etiologies to this disease entity
[4]. The typical cutaneous manifestations of calciphylaxis,
also seen in calcinosis cutis, comprise exquisitely tender
and ﬁrm lesions with ninety percent located in the lower
extremities [9]. The skin lesions of stellate purpura and
livedo reticularis seen as a result of this disease arise from
microthrombus formation within the small vessels [9, 10].
Both proximal and distal lesions can occur although the
proximal lesions are usually located on the thighs and the
lower abdomen. The proximal location helps to distinguish
this disease from vascular causes of lower extremity skin
necrosis.
2.CaseReport
This is the case of a 56-year-old Caucasian woman with
extensive medical problems who initially presented with
bilateral ﬁrm thigh lesions that are extremely painful and
tender to touch (Figure 1). Her past medical history is
complicated by type II diabetes, morbid obesity (BMI >35),
and medically managed chronic renal insuﬃciency with
a baseline creatinine level of 3.0mg/dL. Interestingly, the
patient had a history of poor wound healing following a
hysterectomy in the past. Initial management consisted of
a skin biopsy of these thigh lesions which led to the conﬁr-
mation of calciphylaxis. Histologically, there were extensive
calciﬁcationswithinthesubcutaneoustissueandsmallblood
vessels (Figures 2 and 3). Surveillance chemistries revealed a
preoperative intact PTH level of 737pg/mL, with concurrent
calcium level of 9.7mg/dL, chloride level of 107mmol/L,
and phosphate level of 8.4mg/dL. Preoperative vitamin D
levels were examined and showed a normal total 25 hydroxy-
vitamin D levels of 39ng/mL. She then underwent elective
parathyroidectomy with intraoperative PTH monitoring.
Intraoperatively, the patient was found to have an enlarged
nodular goiter as well as a 1.3-cm papillary carcinoma of
the thyroid. Surprisingly, the patient was also found to have
fournormalparathyroidsbutanaberrantlylocatedadenoma
within the thymic tissue of the mediastinum, weighing
0.62 grams (Figure 4). Intraoperative PTH level remained
elevated (>300pg/mL) after excisional biopsy of three nor-
mally appearing parathyroid glands. Finally, the levels fell to
79pg/mL after the removal of the enlarged adenoma, with a
postoperative repeat value of 57pg/mL. Postoperatively, the
patient’s thigh wound started to granulate with immediate
improvement in her thigh pain.
3. Discussion
Historically, the ﬁrst reported case of calciphylaxis from
hyperparathyroidism was described by Ellis and Barr in
1951 [11]. The authors reported ﬁndings of a 29-year-old
femalewithmetastaticrecurrentparathyroidcarcinomawho
had classic lesions of calciphylaxis during autopsy ﬁndings
[12]. The recognition of this disease entity follows the
early descriptions of Selye et al. in laboratory models of
calciphylaxis [2, 3]. As the understanding of calciphylaxis
becamemorewidespread,reportedcasesofunusualcausesof
Figure 1: The appearance of our patient’s bilateral thigh wounds
showing ﬁrm cutaneous lesions that were exquisitely tender. The
lesions are located in the proximal lower extremity on the lateral
aspects of the thighs.
Figure 2:Skinbiopsywithdemonstrationofvascularcalciﬁcations.
calciphylaxis also became more frequent [4, 5] .As e a r c hi n t o
the available data in the English literature identiﬁed a total
of 15 other cases of patients with calciphylaxis secondary
to primary hyperparathyroidism, with half of them being
reportedinthelastdecade[9,11–22](Table 1).Themajority
of patients succumbed to their disease due to the progressive
natureofthedisease[10].However,afewpatientsdidbeneﬁt
from early parathyroidectomy and medical optimization [9,
12–18].
Initial reports of calciphylaxis secondary to nonrenal-
related causes were usually a result of autopsy ﬁndings [11,
19, 20]. Bogdonoﬀ and colleagues associated two autopsy
ﬁndings of calciphylaxis with parathyroid adenomas in those
patients in 1956 [19]. Both patients were males, which is
much less common than females. Subsequently, Anderson et
al. and Winkelman et al. also found parathyroid adenomas
on autopsy ﬁndings of two sixty-two year old females and
a sixty year old female in 1968 and 1970, respectively
[9, 20]. With better understanding of the physiology of
hyperparathyroidism and its eﬀects on calcium homeostasis,
surgeons are taking a more active role in treating this disease
to decrease serum calcium levels in the hope of controlling
the systemic manifestations associated with hypercalcemia.
Winkelman et al. introduced parathyroidectomy as a man-
agement option in these patients and reported the ﬁrstInternational Journal of Endocrinology 3
Table 1: A list of documented calciphylaxis secondary to primary hyperparathyroidism in the world literature.
Case Age/Sex Pathology Diagnosis Intervention Outcome Reference
(1) 29F Carcinoma Autopsy Autopsy Deceased [11]
(2) 69M Adenoma Autopsy Autopsy Deceased [19]
(3) 44M Adenoma Autopsy Autopsy Deceased [19]
(4) 62F Adenoma (1.0g) Autopsy Autopsy Deceased [20]
(5) 62F Adenoma (6.9g) Surgery Surgery Recovered [9]
(6) 60F Carcinoma with metastases Autopsy Autopsy Deceased [9]
(7) 71F Adenoma Surgery Surgery Recovered [12]
(8) 46F Unknown Leg ulcers Steroids & Immunosupp. Recovered [13]
(9) 72F Adenoma Leg ulcers Conservative Management Deceased [21]
(10) 69F Adenoma (0.5g) Surgery Surgery Recovered [14]
(11) 62F Hyperplasia Leg ulcers Surgery Recovered [17]
(12) 49F Adenoma (0.6g) Leg ulcers Surgery Recovered [16]
(13) 76F Adenoma (0.33g) Leg ulcers Surgery Recovered [18]
(14) 52F Adenoma Surgery Surgery Recovered [15]
(15) 52F Adenoma Leg ulcers Surgery Deceased [22]
(16) 56F Adenoma (0.62g) Leg ulcers Surgery Recovered Bishop et al. 2010
Figure 3: Skin biopsy with demonstration of cutaneous deposition
of calciﬁcations in addition to the vascular calciﬁcations.
patient recovering from calciphylaxis caused by hyper-
parathyroidismin1970[9].Thesecondpublishedreportofa
patient surviving after parathyroidectomy for hyperparathy-
roidism causing calciphylaxis was by Khaﬁf et al. in 1989,
on a 71-year-old female [12]. Despite the more aggressive
approach undertaken recently, patients with calciphylaxis
still have a guarded prognosis, with 80% succumbing to their
disease secondary to recurrent skin infections [10, 23]. The
disease can recur or their wounds can become progressive
even without continued hypercalcemia. Even the role of
parathyroidectomyisassociatedwithmuchcontroversy[10].
Hafner et al. reported a survival advantage for patients
who underwent parathyroidectomy in comparison to those
who did not [23]. However, both Chan et al. and Roe et
al. reported in their series that parathyroidectomy was not
associated with a survival advantage in patients with end-
stage renal disease [10, 24].
Calciphylaxis is not always a disease secondary to unop-
posed parathyroid hormone production from an aberrant
Figure 4: Evidence of primary hyperparathyroidism with hyper-
plastic cells within the parathyroid tissue. A paucity of adipose tis-
sue is visible in the gland, suggesting the presence of a hyperplastic
parathyroid.
gland. Buxtorf et al. presented an interesting case of a
patient with hypercalcemia that was successfully managed
with steroids and immunosuppression alone [4, 13]. There
are also cases of calciphylaxis without association with renal
failure or hyperparathyroidism reported in the literature
[5]. This also correlates with the ﬁnding that patients with
end-stage renal failure can have progressive calciphylaxis
following renal transplantation and normalization of their
parathyroid levels. It appears that once the disease process
initiates following sensitization with hyperparathyroidism,
there is diﬃculty in resetting the calcium homeostatic
switch. However, parathyroidectomy may be the only option
in these diﬃcult cases especially with documented hyper-
parathyroidism, as evidenced by favorable results with early
intervention recently [25].
This patient illustrates the various etiologies that can
lead to calciphylaxis as well as the diﬃculty in managing
this disease entity. Her disease presented with calciphylaxis
secondary to primary hyperparathyroidism that improved4 International Journal of Endocrinology
with the use of parathyroidectomy. However, her chronic
renal insuﬃciency and dysregulation of electrolyte balances
initially suggested secondary hyperparathyroidism as the
culprit for her calciphylaxis. Only during the surgery did we
diagnose the presence of a single adenoma that resulted in
the hyperparathyroidism. Vitamin D, though replete in this
patient, can sometimes be a contributor to the development
of hyperparathyroidism when deﬁcient. In patients with
calciphylaxis, early parathyroidectomy may still play a role
in improving their cutaneous disease, especially in cases of
hyperparathyroidism.
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